BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 3202264)

  • 1. Radioiodine therapy for differentiated thyroid carcinoma.
    Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
    Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.
    Hundeshagen H
    Eur J Nucl Med; 1983; 8(12):541-5. PubMed ID: 6667704
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
    Leung SF; Law MW; Ho SK
    Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of thyroid carcinoma imaging after therapeutic doses of radioiodine.
    Balachandran S; Sayle BA
    Clin Nucl Med; 1981 Apr; 6(4):162-7. PubMed ID: 7214771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
    Ramanna L; Waxman AD; Brachman MB; Tanasescu DE; Sensel N; Braunstein GD
    Clin Nucl Med; 1985 Nov; 10(11):791-5. PubMed ID: 4075672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer.
    Maxon HR
    Q J Nucl Med; 1999 Dec; 43(4):313-23. PubMed ID: 10731782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
    Takada Y; Ohta Y; Kawasaki S; Maki M; Hiroe M; Kusakabe K; Shigeta A; Yamazaki T; Fujimoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):962-70. PubMed ID: 3658666
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
    Bricout P; Kibler RS
    J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
    [No Abstract]   [Full Text] [Related]  

  • 11. Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans.
    Koral KF; Adler RS; Carey JE; Beierwaltes WH
    J Nucl Med; 1986 Jul; 27(7):1207-11. PubMed ID: 3723194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prophylactic postoperative 131I therapy for extended differentiated carcinoma of the thyroid gland.
    Nagahara K; Yoza T; Naito Y; Konishi J; Fujita N
    Auris Nasus Larynx; 1985; 12 Suppl 2():S67-71. PubMed ID: 3836658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

  • 15. Radionuclide diagnosis and therapy of thyroid cancer: current status report.
    Freitas JE; Gross MD; Ripley S; Shapiro B
    Semin Nucl Med; 1985 Apr; 15(2):106-31. PubMed ID: 2988129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
    Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
    An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
    [No Abstract]   [Full Text] [Related]  

  • 18. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.